Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Melt Pharmaceuticals
AddedFeb 17, 2024
UpdatedJun 18, 2026
Melt Pharmaceuticals

Melt Pharmaceuticals

Series D

Melt Pharmaceuticals: Innovating non-opioid sedation for short-term medical procedures.

HQ
Brentwood, TN, US
Founded
2019
Overview
Compare
Fundraising
Employees

Melt Pharmaceuticals is dedicated to innovating non-opioid sedation solutions for short-term medical procedures. Their core mission is to provide safer, effective alternatives to traditional opioid-based sedation, addressing a critical need in medical settings. The company focuses on developing and commercializing novel sedation and analgesia products that enhance patient care and safety.

Melt Pharmaceuticals has made significant strides in the field of procedural sedation, contributing to the reduction of opioid dependency and improving patient outcomes. Their pioneering work has garnered attention and support from the medical community and investors, positioning them as a key player in the healthcare industry.

Melt Pharmaceuticals - Similar Companies

Mirata Pharmaceuticals logo

Mirata Pharmaceuticals

Reset Pharmaceuticals logo

Reset Pharmaceuticals

PleoPharma logo

PleoPharma

pleopharma.com

Amalgent Therapeutics logo

Amalgent Therapeutics

amalgent.com

Tremeau Pharmaceuticals logo

Tremeau Pharmaceuticals

Quartet Medicine logo

Quartet Medicine

Concentric Analgesics logo

Concentric Analgesics

Melior Pharmaceuticals logo

Melior Pharmaceuticals

Metera Pharmaceuticals logo

Metera Pharmaceuticals

Faze Medicines logo

Faze Medicines

fazemed.com

Meitheal Pharmaceuticals logo

Meitheal Pharmaceuticals

meithealpharma.com

Santi Therapeutics logo

Santi Therapeutics

Melior Discovery logo

Melior Discovery

Woolsey Pharmaceuticals logo

Woolsey Pharmaceuticals

woolseypharma.com

Manhattan Pharmaceuticals logo

Manhattan Pharmaceuticals

Melt Pharmaceuticals - Quick Facts

Who are Melt Pharmaceuticals' competitors?

Companies similar to Melt Pharmaceuticals include Mirata Pharmaceuticals, Reset Pharmaceuticals, PleoPharma and Amalgent Therapeutics.

When was Melt Pharmaceuticals founded?

Melt Pharmaceuticals was founded in 2019.

Where is Melt Pharmaceuticals' headquarters located?

Melt Pharmaceuticals' headquarters is located in Brentwood, TN, US.

When was Melt Pharmaceuticals' last funding round?

Melt Pharmaceuticals' most recent funding round was for $39M (USD) in August 2023.

How much has Melt Pharmaceuticals raised to-date?

As of Aug 11, 2023, Melt Pharmaceuticals has raised a total of $50M (USD).

How many employees does Melt Pharmaceuticals have?

Melt Pharmaceuticals has 5 employees as of Feb 5, 2024.

Melt Pharmaceuticals - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research